# Antonio E. Blanco, M.D. – FDA Inspection, Jan 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/antonio-e-blanco-md/d164703d-fd78-4dc5-b3da-e9f2b0f2adb8
Source feed: FDA_Inspections

> FDA inspection 1196096 of Antonio E. Blanco, M.D., January 30, 2023. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1196096
- Company Name: Antonio E. Blanco, M.D.
- Inspection Date: 2023-01-30
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1259612 - 2025-01-24
- FDA Inspection 1114128 - 2019-12-05

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/richard-a-lyght/8d60b5c0-4acd-4abc-979a-fb4b3e82964d)

Company: https://www.keypedia.com/companies/antonio-e-blanco-md/ef043a91-20ad-4b64-9802-6b8a8c8f937f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c